Drotaverine Darnytsia 40 mg Tablets (30 pcs) – Antispasmodic Pain

Drotaverine Darnytsia 40 mg Tablets (30 pcs) – Antispasmodic Pain

Drotaverine Darnytsia 40 mg tablets (30 pcs) are a trusted antispasmodic medicine formulated with drotaverine hydrochloride — a smooth muscle relaxant that helps reduce painful spasms in several internal systems of the body. Designed for oral use, this 30-tablet pack offers a practical supply for managing conditions involving smooth muscle cramps, whether due to gastrointestinal, biliary, urinary or gynecological causes.

The active ingredient, drotaverine, belongs to the benzylisoquinoline group of antispasmodics. It works by inhibiting phosphodiesterase-4 (PDE4), which increases levels of cyclic adenosine monophosphate (cAMP) within smooth muscle cells. This leads to relaxation of the smooth muscle fibres, helping to ease spasms and reduce associated discomfort and pain.

How Drotaverine Works

When smooth muscles — such as those in the digestive tract, biliary system, urinary tract or uterus — contract more than normal, painful cramps or spasms can occur. Drotaverine specifically targets these smooth muscles, helping them to relax by interrupting the signalling that causes contraction. This can ease symptoms associated with:

• Abdominal cramps due to gastrointestinal spasm, irritable bowel or colonic tension.

• Biliary colic and spasms linked to gallbladder disorders.

• Urinary tract spasms from conditions like cystitis or kidney/ureter stones.

• Menstrual pain (dysmenorrhea) from uterine muscle spasms.

This targeted action helps reduce pain and discomfort in conditions that involve involuntary muscle contractions, offering a useful support treatment in daily life or during illness.

Key Benefits

• Relieves smooth muscle spasms in the gastrointestinal, biliary and urinary systems.

• Helps ease menstrual cramps and tension headaches caused by muscular spasms.

• Supports digestive comfort, especially where spasms cause nausea or discomfort.

• Improves smooth muscle relaxation without targeting the central nervous system.

• Convenient oral tablets make dosing simple and easy.

These benefits make Drotaverine Darnytsia an effective choice when short-term relief from painful cramps is needed. It is often recommended as part of a treatment plan under medical supervision.

Indications – When to Use

Drotaverine Darnytsia may be used when prescribed by a healthcare provider for relief from:

• Biliary tract spasms and pain due to gallbladder conditions.

• Urinary tract muscle spasms such as those from nephrolithiasis or cystitis.

• Gastrointestinal spasms including gastritis, enteritis, colitis or spastic constipation.

• Tension headaches linked to smooth muscle tension.

• Dysmenorrhea (menstrual cramps) and other gynecological spasm pain.

Important: Drotaverine should be used as directed by a healthcare professional based on your specific symptoms and medical history.

How to Take (Dosage & Administration)

Adults:

• The typical total daily dose ranges from 120 mg to 240 mg, divided into 2–3 doses throughout the day (commonly 3–6 tablets per day).

Children (when prescribed):

• 6–12 years: Maximum daily dose is around 80 mg, divided between doses.

• Over 12 years: Up to 160 mg daily, split across doses.

Always follow the dosage instructions on the package or from your doctor. Do not exceed recommended doses without medical advice.

Safety & Precautions

Drotaverine is not suitable for everyone and special precautions include:

• Allergy: Do not take if allergic to drotaverine or any tablet components.

• Severe liver, kidney or heart conditions: Use is not recommended without medical supervision.

• Pregnancy & breastfeeding: Use caution and consult your doctor — while animal studies show no clear injury, human data is limited.

• Driving & machinery: If you experience dizziness, avoid activities requiring alertness.

Make sure your doctor is aware of all medications you are taking, as drug interactions may occur — for example, drotaverine can influence the effectiveness of levodopa, reducing its antiparkinsonian action.